# Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

> **NCT03413982** · — · RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 1000 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **OTHER:** Registry

## Key facts

- **NCT ID:** NCT03413982
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-11-02
- **Primary completion:** 2035-01-01
- **Final completion:** 2035-01-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03413982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03413982, "Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03413982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*